Entecavir ( Xvir 0.5mg Tablet)

Get a Price/Quote

MOQ : 10 Pieces

Entecavir ( Xvir 0.5mg Tablet) Specification

Appearance
White to off-white tablet

Origin of Medicine
India

Dosage
0.5 mg

Grade
IP (Indian Pharmacopoeia)

Expiration Date
24 to 36 months from manufacture

Storage
Store below 30C, protect from moisture

Medicine Type
Tablet

Indication
Chronic Hepatitis B infection

Salt Composition
Entecavir 0.5 mg

Usage
Antiviral, for the treatment of chronic hepatitis B virus infection

CAS No
209216-23-9

Pacakaging (Quantity Per Box)
30 Tablets

Molecular Formula
C12H15N5O3

Assay
Not less than 98% and not more than 102%

Dosage Form
Oral tablet

Prescription Required
Yes

Shape
Tablet, film-coated

Type of Medicine
Prescription Only (Rx)

Color
White

Pack Size
Plastic bottle of 30 tablets

Inactive Ingredients
Lactose, microcrystalline cellulose, other excipients

Precaution
Use with caution in patients with renal impairment or HIV infection without HAART

Strength
0.5 mg per tablet

Brand Name
X-VIR

Route of Administration
Oral

Intended Patient
Adults and adolescents (above 16 years) with HBV infection

Label Claim
Entecavir tablets I.P. 0.5 mg

Entecavir ( Xvir 0.5mg Tablet) About

Unlock radiant health with X-VIR (Entecavir 0.5mg Tablet), an exclusive antiviral for the splendiferous management of chronic hepatitis B virus infection. Designed for adults and adolescents over 16, each scarce, film-coated white tablet delivers a potent 0.5mg, ensuring assured results for eligible patients. This prescription-only, IP-graded medicine is rigorously assayed (98%-102%), signifying unmatched purity. Its ravishing efficacy makes X-VIR a highly sought-after choice for long-term viral suppression. Store below 30C in moisture-protected bottles of 30 for peak potency and stability.

Distinctive Features & Application Spectrum

X-VIR (Entecavir 0.5mg Tablet) offers a splendiferous solution to chronic HBV infection, targeting viral replication at the molecular level for maximal benefit. This oral tablet is indicated exclusively for adults and adolescents above 16 years old, ensuring targeted therapy. Its white, film-coated design guarantees convenient administration and supreme tolerability, with special caution in those with renal impairment or HIV infection not on HAART. X-VIR is crafted for clinical brilliance, setting a radiant standard for antiviral care.

Export Markets & Certification Details

X-VIR (Entecavir 0.5mg Tablet) is shipped globally from India to diverse export markets, including Asia, Africa, and Latin America. Swift order completion and reliable delivery are assured via designated FOB ports. Each batch is meticulously certified under Indian Pharmacopoeia (IP) standards, guaranteeing pharmaceutical grade quality for international partners. The splendiferous packaging, in bottles of 30 tablets, ensures product integrity throughout worldwide distribution, making X-VIR a ravishingly dependable choice for healthcare traders and suppliers.

FAQ's of Entecavir ( Xvir 0.5mg Tablet):

Q: How should X-VIR (Entecavir 0.5mg Tablet) be administered?

A: X-VIR should be taken orally, once daily, as prescribed by a healthcare professional, preferably on an empty stomach for optimal absorption.

Q: What precautions should be observed when using X-VIR?

A: Use X-VIR with caution in patients with renal impairment or in those with HIV infection who are not receiving HAART, as special monitoring may be necessary.

Q: When is it appropriate to use X-VIR for hepatitis B infection?

A: X-VIR is intended for adults and adolescents (above 16 years) who have been diagnosed with chronic hepatitis B virus infection and require antiviral treatment.

Q: Where is X-VIR manufactured and exported from?

A: X-VIR is manufactured in India, adhering to Indian Pharmacopoeia standards, and is exported to various international markets through certified FOB ports.

Q: What are the benefits of using X-VIR for HBV infection?

A: X-VIR provides effective suppression of the hepatitis B virus, helping to reduce viral load and minimize liver damage in eligible patients when used as prescribed.